Fenfluramine
-
Subject Areas on Research
- Adolescent male rats are less sensitive than adults to the anxiogenic and serotonin-releasing effects of fenfluramine.
- Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation.
- Circulatory effects of fenfluramine in obese hypertensive patients.
- Couples training, pharmacotherapy, and behavior therapy in the treatment of obesity.
- Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice.
- Differential changes in plasma high-density lipoprotein-cholesterol levels in obese men and women during weight reduction
- Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
- Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies.
- Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities.
- Inhibition of suckling in weaning-age rats: a possible serotonergic mechanism.
- Plasma fenfluramine levels, weight loss and side effects: a failure to find a relationship.
- Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication.
- Role of serotonin in hypothalamo pituitary adrenal axis escape from dexamethasone suppression.
- Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
- Session highlights from the American College of Cardiology Scientific Sessions: March 29 to April 1, 1998.
- Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction.
- The double-blind in danger: untoward consequences of informed consent.
- The progression of fenfluramine-associated valvular heart disease assessed by echocardiography.
- The relationship between health-related quality of life and weight loss.